• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用氧化铁剂进行肝脏动态成像:尺寸和生物分布对造影的影响。

Dynamic liver imaging with iron oxide agents: effects of size and biodistribution on contrast.

作者信息

Mandeville J B, Moore J, Chesler D A, Garrido L, Weissleder R, Weisskoff R M

机构信息

MGH-NMR Center, Charlestown, MA 02129, USA.

出版信息

Magn Reson Med. 1997 Jun;37(6):885-90. doi: 10.1002/mrm.1910370613.

DOI:10.1002/mrm.1910370613
PMID:9178240
Abstract

In vivo effective relaxation rates in normal rat liver were evaluated for four dextran coated iron oxide agents: monocrystalline iron oxide nanocolloid (MION) with a mean particle diameter of 3.9 nm, a polycrystalline agent (PION) with a larger mean diameter of 12 nm, and these two agents labeled with the asialofetuin (ASF) protein for high hepatocytic receptor binding affinity (MION-ASF and PION-ASF). Using echo planar imaging at 2 Tesla, dose response was measured with measured with high temporal resolution for 3 h after injection of agent, and by comparing with relaxivities in vitro and in brain, dominant in vivo contrast phenomena were elucidated. While transverse relaxivity for PION-ASF exceeded that for MION-ASF by almost a factor of 2 in solution, relaxation rates in vivo became equivalent. Liver relaxation using non-ASF agents was consistent with rapid water exchange between vascular and extravascular compartments, which dominated relaxation as a result of agent accumulation in Kupffer cells.

摘要

对四种葡聚糖包被的氧化铁制剂评估了正常大鼠肝脏中的体内有效弛豫率

平均粒径为3.9 nm的单晶氧化铁纳米胶体(MION)、平均粒径较大为12 nm的多晶制剂(PION),以及这两种与去唾液酸胎球蛋白(ASF)蛋白结合以实现高肝细胞受体结合亲和力的制剂(MION-ASF和PION-ASF)。在2特斯拉下使用回波平面成像,在注射制剂后3小时内以高时间分辨率测量剂量反应,并通过与体外和脑内的弛豫率进行比较,阐明了主要的体内对比现象。虽然在溶液中PION-ASF的横向弛豫率比MION-ASF高出近2倍,但体内弛豫率变得相当。使用非ASF制剂时肝脏的弛豫与血管和血管外间隙之间的快速水交换一致,由于制剂在库普弗细胞中的积累,这种水交换主导了弛豫。

相似文献

1
Dynamic liver imaging with iron oxide agents: effects of size and biodistribution on contrast.使用氧化铁剂进行肝脏动态成像:尺寸和生物分布对造影的影响。
Magn Reson Med. 1997 Jun;37(6):885-90. doi: 10.1002/mrm.1910370613.
2
MION-ASF: biokinetics of an MR receptor agent.
Magn Reson Imaging. 1993;11(3):411-7. doi: 10.1016/0730-725x(93)90074-n.
3
Contrast enhancement in experimental radiation-induced liver injury: comparison of hepatocellular and reticuloendothelial particulate contrast agents.
J Magn Reson Imaging. 1996 Mar-Apr;6(2):286-90. doi: 10.1002/jmri.1880060205.
4
An organotypical in vitro model of the liver parenchyma for uptake studies of diagnostic MR receptor agents.
Magn Reson Imaging. 1995;13(7):991-1002. doi: 10.1016/0730-725x(95)00053-j.
5
A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent.
Magn Reson Imaging. 1990;8(5):637-46. doi: 10.1016/0730-725x(90)90143-p.
6
Application of a stable cell culture assay for the functional assessment of novel MR contrast agents.
Eur Radiol. 1997;7(4):527-31. doi: 10.1007/s003300050197.
7
Receptor-mediated introduction of pepstatin-asialofetuin conjugate into lysosomes of rat hepatocytes.受体介导的胃蛋白酶抑制剂-去唾液酸胎球蛋白共轭物导入大鼠肝细胞溶酶体。
J Biochem. 1983 Jan;93(1):249-56. doi: 10.1093/oxfordjournals.jbchem.a134160.
8
Non-invasive detection of protein metabolism in vivo by n.m.r. spectroscopy. Application of a novel 19F-containing residualizing label.通过核磁共振光谱对体内蛋白质代谢进行无创检测。一种新型含氟-19残留标记物的应用。
Biochem J. 1989 Dec 15;264(3):829-35. doi: 10.1042/bj2640829.
9
Contrast-enhanced MR imaging of two superparamagnetic RES-contrast agents: functional assessment of experimental radiation-induced liver injury.
J Magn Reson Imaging. 1999 Jul;10(1):52-6. doi: 10.1002/(sici)1522-2586(199907)10:1<52::aid-jmri7>3.0.co;2-c.
10
Asialoglycoprotein receptor mediates the toxic effects of an asialofetuin-diphtheria toxin fragment A conjugate on cultured rat hepatocytes.去唾液酸糖蛋白受体介导去唾液酸胎球蛋白-白喉毒素A片段偶联物对培养的大鼠肝细胞的毒性作用。
Proc Natl Acad Sci U S A. 1981 Jun;78(6):3383-7. doi: 10.1073/pnas.78.6.3383.

引用本文的文献

1
Morphology Effect of PEGylated Iron Oxide Nanoparticles on the Enhancement of MRI Contrast Signal in Breast Cancer.聚乙二醇化氧化铁纳米颗粒对乳腺癌磁共振成像对比信号增强的形态学效应
ACS Appl Mater Interfaces. 2025 Aug 6;17(31):44275-44287. doi: 10.1021/acsami.5c12013. Epub 2025 Jul 28.
2
Imaging Constructs: The Rise of Iron Oxide Nanoparticles.成像构建体:氧化铁纳米粒子的崛起。
Molecules. 2021 Jun 5;26(11):3437. doi: 10.3390/molecules26113437.
3
Quantification and biodistribution of iron oxide nanoparticles in the primary clearance organs of mice using T contrast for heating.
利用 T 对比剂加热定量和研究铁氧化物纳米颗粒在小鼠初级清除器官中的分布
Magn Reson Med. 2017 Aug;78(2):702-712. doi: 10.1002/mrm.26394. Epub 2016 Sep 25.
4
Reduced microvascular volume and hemispherically deficient vasoreactivity to hypercapnia in acute ischemia: MRI study using permanent middle cerebral artery occlusion rat model.急性缺血时微血管容积减少及对高碳酸血症的半球性血管反应性不足:使用永久性大脑中动脉闭塞大鼠模型的MRI研究
J Cereb Blood Flow Metab. 2015 Jun;35(6):1033-43. doi: 10.1038/jcbfm.2015.22. Epub 2015 Feb 18.
5
biodistribution of iron oxide nanoparticles: an overview.氧化铁纳米颗粒的生物分布:概述
Proc SPIE Int Soc Opt Eng. 2011 Feb 22;7901:790117. doi: 10.1117/12.876414.
6
Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals.基于物理和生物学的新一代分子成像探针的合理化学设计:混合模态、颜色和信号。
Chem Soc Rev. 2011 Sep;40(9):4626-48. doi: 10.1039/c1cs15077d. Epub 2011 May 23.
7
Simulating Magnetic Nanoparticle Behavior in Low-field MRI under Transverse Rotating Fields and Imposed Fluid Flow.横向旋转场和外加流体流动条件下低场磁共振成像中磁性纳米颗粒行为的模拟
J Magn Magn Mater. 2010 Sep;322(17):2607-2617. doi: 10.1016/j.jmmm.2010.03.029.
8
Current trends and challenges in MRI acquisitions to investigate brain function.用于研究脑功能的磁共振成像采集的当前趋势与挑战。
Int J Psychophysiol. 2009 Jul;73(1):33-42. doi: 10.1016/j.ijpsycho.2008.12.020. Epub 2009 Feb 21.
9
Pre-clinical results with Clariscan (NC100150 Injection); experience from different disease models.
MAGMA. 2001 May;12(2-3):99-103. doi: 10.1007/BF02668090.
10
'NC100150', a preparation of iron oxide nanoparticles ideal for positive-contrast MR angiography.“NC100150”,一种适用于阳性对比剂磁共振血管造影的氧化铁纳米颗粒制剂。
MAGMA. 1999 Aug;8(3):207-13. doi: 10.1007/BF02594600.